# Volatile Organic Compounds as Markers of Acute Rejection in Lung Transplant

> **NCT03172091** · NA · UNKNOWN · sponsor: **Hopital Foch** · enrollment: 120 (estimated)

## Conditions studied

- Transplant; Complication, Rejection

## Interventions

- **DEVICE:** eNose (electronic nose)
- **DEVICE:** Spectrometry

## Key facts

- **NCT ID:** NCT03172091
- **Lead sponsor:** Hopital Foch
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-27
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03172091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03172091, "Volatile Organic Compounds as Markers of Acute Rejection in Lung Transplant". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03172091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*